At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...

Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.

The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).

Diabetic foot ulcers are a common and costly complication for people with diabetes. ON101 is a promising new topical treatment anticipated for FDA approval in the coming...

People dealing with access to food are more likely to have overweight, obesity, or type 2 diabetes. If you face barriers to accessing nutritious foods, there are...

Research shows screening children ages 2-6 best predicts childhood type 1 diabetes. Early screening also leads to more timely treatment, better outcomes, and reduced...

The debate over how many carbohydrates people should consume has raged for decades. Experts share their perspectives on low, very low, and moderate carb diets for ideal...

Obesity management options include lifestyle changes, medication, and surgery. Here's what you need to know to make informed decisions about what treatments are optimal...

Explore the role of artificial intelligence in diabetic retinopathy detection with Eyenuk's innovative technology. Here we also examine the disputed effects of GLP-1s on...

At the 17th annual Diabetes Forum at ADA 2023, the diaTribe Foundation and TCOYD moderated an expert panel that discussed access and equity issues, breakthrough...

A lot has happened this year advancing time in range as a primary glucose metric in diabetes care globally. Though we aren’t there yet, a panel shared their thoughts on...

Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at...

PIONEER PLUS and OASIS 1 trials show high-dose Rybelsus significantly reduces A1C and promotes weight loss in type 2 diabetes and obesity patients.

Trying to figure out the best nutrition options as a person with diabetes can be a daunting task, and often there are mixed messages about what the best food options are.

Clinical trial results have shown that once-weekly basal insulins are just as effective at reducing A1C as once-daily insulin.

A panel shared insights at the ADA’s 83rd Scientific Sessions on incorporating hypoglycemia as a quality measure in diabetes. Each expert noted the importance of...

Results from a recent clinical trial showed the new medication survodutide may be a useful treatment tool for weight loss. People with overweight or obesity on the...

On the search for a type 1 diabetes cure, scientists are experimenting with how to engineer beta cells to survive immune system attacks. At the American Diabetes...

Figuring out when and how to exercise can be one of the most difficult parts of living with diabetes. At the ADA's 83rd Scientific Sessions, experts shared strategies...

People with type 1 and 2 diabetes report experiencing diabetes stigma regardless of which devices they use. But when we start looking at which groups report the most...